Our conference will be composed of four panel discussions and two company presentation sessions showcasing the pipeline of select biotech companies we represent throughout the day.
During our last in-person event in 2020, members and senior executives from more than 600 public & private healthcare companies across the biopharmaceuticals, IVD, medical device, and healthcare services sectors attended our conference. More than 300 PE and VC investors from over 100 firms were also present.
Discussion
By posting you agree to the Terms and Privacy Policy.